INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 49 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,000 | -64.7% | 11,859 | -54.9% | 0.00% | – |
| Q1 2020 | $17,000 | -99.7% | 26,307 | -99.4% | 0.00% | -100.0% |
| Q4 2019 | $5,507,000 | +102.2% | 4,444,000 | +7.4% | 0.02% | +100.0% |
| Q3 2019 | $2,724,000 | – | 4,139,000 | -52.0% | 0.01% | – |
| Q2 2019 | $0 | – | 8,628,000 | +5576.3% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 152,000 | -96.9% | 0.00% | -100.0% |
| Q4 2016 | $4,363,000 | +7691.1% | 4,895,000 | +9690.0% | 0.01% | – |
| Q3 2016 | $56,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|